Integra LifeSciences Holdings IART
Analyst Ratings
- Consensus
- Hold — 0 Buy · 6 Hold · 1 Sell (7 analysts)
- Avg. Price Target
- $17.83 (+40.6% upside)
Key Stats
- Today's Range
- $12.63 – $14.00
- 50-Day Range
- $12.63 – $20.49
- 52-Week Range
- $8.70 – $20.49
- Volume
- 2.70 million shs
- Average Volume
- 878K shs
- Market Cap
- $1.25 billion
- P/E Ratio
- —
- Dividend Yield
- —
Valuation
- P/E Ratio
- —
- Price / Book
- 1.20
- Price / Sales
- 0.76
Short Interest
- Short Interest
- 6.92%
- Days to Cover
- 13.60
Financials (TTM)
- Revenue
- $1.65 billion
- Net Income
- $-7,242,000
- Net Margin
- -0.44%
- Return on Equity
- -0.69%
- Debt-to-Equity
- 0.68
About Integra LifeSciences Holdings
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.
Related Stocks
Compare head-to-head: IART vs SYK·IART vs BSX·IART vs RMD·IART vs BAX
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.